Sign In
Buy ZYME
$24.35
+0.240 (+1.00%)
At Close: Jun 03, 2026
Why Shares of Zymeworks Rose 12.18% on Monday
04:42pm, Monday, 31'st Oct 2022
The biotech stock's shares may have been pushed by a short squeeze.
Jazz Pharmaceuticals' Deal With Zymeworks Offers Good Reward-Risk Ratio
09:02am, Wednesday, 26'th Oct 2022
Jazz Pharmaceuticals will pay $50 million upfront for an option to in-license Zymeworks' zanidatamab. Zymeworks carries most of the risk until Jazz opts in. If the deal goes through, Zymeworks would b
Zymeworks: A Binary Event With BTC Data By End-2022 Which May Trigger Milestone
04:38am, Wednesday, 26'th Oct 2022
Zymework's Jazz deal will bring $325mn in milestone payment if zanidatamab's BTC data is good. BTC data comes out by end 2022.
Analyst Moves To Sidelines After Jazz Pharma Deal Shifts Zymeworks To Early Stage Pipeline
05:35pm, Friday, 21'st Oct 2022 Benzinga
SVB Leerink downgraded Zymeworks Inc (NASDAQ: ZYME) to Market Perform with a price target of $8, down from $19 following the recent divestiture of zanidatamab to Jazz Pharmaceuticals plc (NASDA
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
02:11pm, Friday, 21'st Oct 2022 Benzinga
Upgrades
SVB Leerink upgraded the previous rating for Moderna Inc (NASDAQ:MRNA) from Underperform to Market Perform. Moderna earned $5.24 in the second quarter, compared to $6.46 in the year-ago quart
Zymeworks (ZYME) Up on Licensing Deal With Jazz Pharmaceuticals
05:36pm, Thursday, 20'th Oct 2022 Zacks Investment Research
Zymeworks (ZYME) inks a deal to license its lead candidate, zanidatamab, to Jazz Pharmaceuticals for the development and commercialization of the candidate in all territories except Asia-Pacific.
Zymeworks Inc. (ZYME) Surges 15.9%: Is This an Indication of Further Gains?
03:48pm, Thursday, 20'th Oct 2022 Zacks Investment Research
Zymeworks Inc. (ZYME) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down
Zymeworks (ZYME) Up on Licensing Deal With Jazz Pharmaceuticals
03:03pm, Thursday, 20'th Oct 2022
Zymeworks (ZYME) inks a deal to license its lead candidate, zanidatamab, to Jazz Pharmaceuticals for the development and commercialization of the candidate in all territories except Asia-Pacific.
Zymeworks Inc. (ZYME) Surges 15.9%: Is This an Indication of Further Gains?
01:33pm, Thursday, 20'th Oct 2022
Zymeworks Inc. (ZYME) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down
Intuitive Surgical, Netflix, ASML And Other Big Gainers From Wednesday
08:39am, Thursday, 20'th Oct 2022 Benzinga
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping 100 points. Here is the list of some big stocks recording gains in the previous session.
Amprius Technologies, Inc. (NYSE: AMPX) jum
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
05:52am, Thursday, 20'th Oct 2022 Benzinga
Gainers
Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of E
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
04:30pm, Wednesday, 19'th Oct 2022 Benzinga
Gainers
SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.
Scopus BioPharma Inc. (NASDAQ:
Why Zymeworks Stock Is Soaring Today
03:08pm, Wednesday, 19'th Oct 2022 The Motley Fool
Investors applauded a major licensing deal with Jazz Pharmaceuticals.
Why Zymeworks Stock Is Soaring Today
11:08am, Wednesday, 19'th Oct 2022
Investors applauded a major licensing deal with Jazz Pharmaceuticals.
Why Is Zymeworks (ZYME) Stock Up Today?
10:13am, Wednesday, 19'th Oct 2022
Zymeworks (NYSE: ZYME ) stock is climbing higher on Wednesday after the company signed a licensing agreement with Jazz Pharmaceuticals (NASDAQ: JAZZ ). This agreement has Jazz Pharmaceuticals acquirin
